The Exchange has sought clarification from Colinz Laboratories Ltd on June 1, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 5.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
BSE has asked Colinz Laboratories Ltd to provide clarification regarding an unusual and significant movement in the company's share price, observed around June 1, 2026. The exchange has made this query to ensure that investors have access to the latest and most relevant information about the company. Such clarification requests are routine and are triggered when the exchange notices abnormal trading activity. The company is expected to respond within the stipulated timeframe with any material information or clarify that no such information is pending.
This is a regulatory query and not an adverse action. It creates short-term uncertainty until the company responds, but on its own does not signal any negative event. Investors should watch for the company's reply, as it may contain material disclosures or confirm there is nothing to disclose.